Stock screener

XERS

Conviction 65HealthcareScan · Fri, Jun 26, 2026
XERS$7.65+3.38%
ResistanceSupportVol 14Insider sell
63 bars
3
Vol MA14 1.92M
Mar 27Apr 15May 4May 20Jun 9Jun 26
Xeris Biopharma Holdings, Inc.PHARMACEUTICAL PREPARATIONSwww.xerispharma.com
Price7.65
Change+3.38%
Gap+1.28%
Rel volume1.39×
Avg volume1.82M
Avg $ vol12.33M
SMA 206.69
SMA 506.40
SMA 2007.03
Price vs 50+19.46%
Price vs 200+8.83%
MA stackmixed
50/200 cross
Supertrendup · 6.77
RSI (14)77
MACD hist0.09
MACD cross
Stoch %K / %D94 / 91
ADX (14)40
+DI / −DI35 / 7
RSI divergence
MACD divergence
ATR %+3.56%
ADR %3.76%
52w high9.90
52w low4.66
From 52w high-22.73%
Above 52w low+64.16%
New 52w highNo
SqueezeOff
Bollinger width30.09%
%B0.98
Donchian pos95.34%
Donchian high7.74
Donchian low5.81
AVWAP (52w high)6.79
vs AVWAP high+12.69%
AVWAP (52w low)7.00
vs AVWAP low+9.32%
OBV trendUp
Chaikin MF (20)0.08
Today vs 20d1.39×
Avg vol (14d)1.92M
Avg vol (20d)1.82M
Avg $ vol (20d)12.33M
Market cap
RS 3m (vs SPY)+27.83%
RS 6m (vs SPY)-4.59%
RS line new highYes
Trend template5/8
Technical rank75.9
1 week+10.07%
1 month+22.79%
3 months+37.34%
6 months+5.08%
1 year+62.42%
YTD+4.08%
P/E2309.17
P/B98.32
P/S4.38
P/FCF46.45
EPS0.0000
Div yield
ROE4.26%
ROA0.14%
Debt/Eq17.00
Current2.12
EV/EBITDA52.99
Gross margin
Net margin0.19%
Rev growth43.72%
EPS growth101.01%
Price target12.33
Target upside66.40%
Analyst ratingBuy
Institutional68.35%
Ent. value1.39B
Revenue83.13M
Net income2.23M
Gross profit7.84M
Free cash flow27.54M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out172.64M
Employees435
ListedThu, Jun 21, 2018
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeB
Conviction65 / 100
Pattern quality
Tech rank75.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance7.04
Support5.82
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in XERS

All disclosures →
No recent disclosed trades by Congress in XERS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XERS · 6 buys · 3 sells

InsiderSideShares
HALKUFF DAWN
Director · Common Stock · 2026-06-04
Sell20K
HALKUFF DAWN
Director · Common Stock · 2026-06-04
Grant24.19K
Brady James Aloysius
Director · Stock Option (Right to Buy) · 2026-06-04
Grant33K
HALKUFF DAWN
Director · Stock Option (Right to Buy) · 2026-06-04
Grant33K
JOHNSON JOHN
Director · Common Stock · 2026-06-04
Sell15K
JOHNSON JOHN
Director · Stock Option (Right to Buy) · 2026-06-04
Grant33K
BORMANN-KENNEDY BARBARA-JEAN ANNE
Director · Stock Option (Right to Buy) · 2026-06-04
Grant33K
HALKUFF DAWN
Director · Common Stock · 2026-06-04
Other
Kong Garheng
Director · Common Stock · 2026-06-04
Grant24.19K
BORMANN-KENNEDY BARBARA-JEAN ANNE
Director · Common Stock · 2026-06-04
Sell16K

SEC filings

EDGAR filings in XERS · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.